
Red Book Pediatric Infectious Diseases Clinical Decision Support Chart
Pediatric Infectious Diseases Clinical Decision Support Chart
David W. Kimberlin(Editor)
American Academy of Pediatrics (Publisher)
2nd Edition
Published on 20. July 2021
Book
Spiral bound
38 pages
978-1-61002-508-9 (ISBN)
Description
Fully revised and updated, the second edition of this full-color chart collects many of the most clinically useful tables, algorithms, and other items from the Red Book and presents them in an enlarged, enhanced, colorized format that is lightweight, portable and easy to navigate.
Additionally, new tables have been created exclusively for this chart, synthesizing important clinical information from the Red Book text.
Additionally, new tables have been created exclusively for this chart, synthesizing important clinical information from the Red Book text.
More details
Edition
2nd Revised edition
Language
English
Place of publication
Elk Grove Village
United States
Target group
Professional and scholarly
Edition type
Revised edition
Dimensions
Height: 279 mm
Width: 216 mm
Weight
415 gr
ISBN-13
978-1-61002-508-9 (9781610025089)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions

David W. Kimberlin
Red Book Pediatric Infectious Diseases Clinical Decision Support Chart
E-Book
07/2021
2nd Edition
American Academy of Pediatrics
€59.49
Available for download
Person
David W. Kimberlin, MD, FAAP is the Editor of the 2021 AAP Report of the Committee on Infectious Diseases (Red Book). He also was Editor of the 2015 and 2018 editions and was an Associate Editor of the 2012 and 2009 editions and served on the AAP Committee on Infectious Diseases from 2005- 2011. Dr Kimberlin is the Sergio Stagno, MD. Endowed Chair in Infectious Diseases, Professor and Co-Division Director, Vice Chair for Clinical and Translational Research. His clinical and research interests include pediatric infectious diseases, antiviral therapeutics in rare diseases with a large unmet medical need, including neonatal herpes simplex virus (HSV) infections, congenital cytomegalovirus (CMV) disease, congenital Zika infection, neonatal and infantile influenza infection, and neonatal enteroviral sepsis syndrome.
Content
- 1. Staphylococcal Infections
- 2. Streptococcal Infections
- 3. Diarrheal Infections
- 4. Immunizations (runs for 2 spreads)
- 5. Antibiotic Prophylaxis
- 6. Immune Globulin (runs for 2 spreads)
- 7. Kawasaki Disease
- 8. Tuberculosis
- 9. Lyme Disease
- 10. Varicella-Zoster
- 11. Zika
- 12. Fungal Infections
- 13. Genital and Neonatal Herpes
- 14. Syphilis
- 15. HIV
- 16. Immunocompromised Children and Adolescents
- 2. Streptococcal Infections
- 3. Diarrheal Infections
- 4. Immunizations (runs for 2 spreads)
- 5. Antibiotic Prophylaxis
- 6. Immune Globulin (runs for 2 spreads)
- 7. Kawasaki Disease
- 8. Tuberculosis
- 9. Lyme Disease
- 10. Varicella-Zoster
- 11. Zika
- 12. Fungal Infections
- 13. Genital and Neonatal Herpes
- 14. Syphilis
- 15. HIV
- 16. Immunocompromised Children and Adolescents